Company Profile Senior Management Team Board of Directors Scientific Advisory Board Vision

Overview Protein Misfolding & Disease Pharmacological Chaperones Proposed Mechanism of Action

Pipeline Fabry – AT1001 Gaucher – AT2101 Pompe – AT2220 Ongoing Clinical Trials

Senior Management Team Corporate Governance Press Releases Events & Presentations SEC Filings Stock Performance Investor FAQs Contact Us

Overview Career Opportunities Benefits Working at Amicus

Investors & Media :
John Quirk
Porter Novelli Life Sciences
(212) 601-8296

Press Releases